Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$159.85 +8.21 (+5.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Alnylam Pharmaceuticals (ALNY) Net Margin (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Net Margin came in at 12.74% for Q2 2026, up 22.08 percentage points from -9.34% a year earlier but down 4.91 percentage points from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Net Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alnylam Pharmaceuticals reported Net Margin of 15.26%, up 26.57 percentage points year-over-year; for FY2025, it was 8.45%, up 20.82 percentage points from FY2024.

  • Net Margin has increased in each of the last three years, with a five-year change of +182.59 percentage points (FY2020 to FY2025).
  • Going back by year, Net Margin was -12.37% in FY2024 (+11.71 pp), -24.08% in FY2023 (+84.96 pp), -109.04% in FY2022 (-8.02 pp) and -101.01% in FY2021 (+73.13 pp).
  • The five-year range for quarterly Net Margin is -153.58% (Q3 2022) to 20.10% (Q3 2025).
  • Year-over-year, Net Margin increased in four of the last six quarters, with an average year-over-year change of +9.54 percentage points.
  • The fastest year-over-year change in Net Margin over five years came in Q3 2023 (a gain of 173.27 percentage points), and the weakest in Q3 2022 (a drop of 44.58 percentage points).
  • Business Quant data shows ALNY's Net Margin at 17.65% (Q1 2026), 10.17% (Q4 2025) and 20.10% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Alnylam Pharmaceuticals 20.30 Bn 7.49 Bn 1.10 Bn 148.64%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 148.64%
Jun 30, 2026 12.74%
Mar 31, 2026 17.65%
Dec 31, 2025 10.17%
Sep 30, 2025 23.43%
Jun 30, 2025 -9.34%
Dec 31, 2024 -14.12%
Sep 30, 2024 -22.27%
Jun 30, 2024 -2.56%
Mar 31, 2024 -13.34%
Dec 31, 2023 -31.35%
Sep 30, 2023 19.69%
Jun 30, 2023 -86.59%
Mar 31, 2023 -54.53%
Dec 31, 2022 -61.93%
Sep 30, 2022 -153.58%
Jun 30, 2022 -123.39%
Mar 31, 2022 -112.70%
Dec 31, 2021 -99.97%
Sep 30, 2021 -109.00%
API Access

Alnylam Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY